Researchers at MIT are subject to the Institute’s Conflict of Interest in Research Policy which supports compliance with Federal and sponsor-specific conflict of interest (COI) disclosure requirements. Anyone submitting a COI disclosure should first read the Institute's Conflict of Interest in Research Policy. Any questions about a potential COI or the COI policy should be discussed with the department, lab or center head, or MIT’s COI Officer (firstname.lastname@example.org). We are here to help you.
COI In the News
September 9, 2018
NEW! September 9, 2018 - New York Times - The chief executive of Memorial Sloan Kettering Cancer Center sent an email to all staff members on Sunday saying that the institution and its faculty “need to do a better job” of disclosing their relationships with the drug and health care industries.
July 25, 2018
NEW! The importance of monitoring use of SBIR/STTR funds has come into sharp relief at Purdue University, where a professor and his wife were indicted this week by a grand jury for allegedly defrauding the National Science Foundation, according to an announcement from the U.S. Attorney for the Northern District of Indiana.
June 25, 2018
The Physician Payments Sunshine Act (PPSA) requires health care product manufacturers to report to the federal government payments more than $10 to physicians. Bringing unprecedented transparency to medicine, PPSA holds great potential for enabling medical stakeholders to manage conflicts of interest (COI) and build patient trust—crucial responsibilities of medical professionalism.
January 31, 2018
(CNN) - Dr. Brenda Fitzgerald, director of the US Centers for Disease Control and Prevention, resigned Wednesday, a day after Politico reported Fitzgerald's purchase of tobacco stock after she took the position at the nation's top public health agency.
December 27, 2017
One physician had his prescription pad taken away after he repeatedly failed tests assessing his competency. Another was banned from treating mentally ill inmates and accused of endangering nursing home patients by prescribing excessive dosages of medications. At least three others had criminal convictions for illegal prescribing.
Continuing Steps to Ensuring Credibility of NIH Research: Selecting Journals with Credible PracticesNovember 14, 2017
The scientific community is paying increasing attention to the quality practices of journals and publishers. NIH recently released a Guide notice...
November 6, 2017
CNN - A leading advocacy group for Alzheimer's patients has stopped accepting funding from a Southern California drugmaker following a CNN investigation into the company that sparked a government probe.
October 5, 2017
The scramble for government funding on the university level is a bare-knuckle competitive business. Careers — and fortunes — are often tied directly to getting the right grant at the right time.
August 9, 2017
An investigation of financial misdeeds at an Idaho State University research and innovation center has cost the director of the center his job, and maybe more as the findings are now with the local prosecutor’s office.
Sparking Economic Growth Report
The Science Coalition released a Sparking Economic Growth report that traces the origins of 302 companies – many of them small businesses – back to federally support research. The report is “intended to showcase one of the ways that federal investment in basic scientific research helps stimulate the economy."
A few “Bright Lines” to Remember from the COI Policy:
Investigators may not:
- accept research sponsorship or gifts, in support of the Investigator’s Institutional Responsibilities from a for-profit privately-held Related Entity;
- subcontract to a for-profit privately-held Related Entity;
- negotiate with MIT on behalf of a Related Entity, or negotiate with the Related Entity on behalf of MIT;
- involve a student for whom the Investigator is a thesis supervisor in the Investigator’s Outside Professional Activities;
- divert research opportunities to a Related Entity, which are more appropriately undertaken at MIT, such as research sponsorship or other projects;
- promote the use of products or services of a Related Entity in the course of the Investigator’s Institutional Responsibilities; or
- engage in research involving human subjects that could reasonably be expected to affect the financial condition of a Related Entity.
Questions or comments? E-mail email@example.com